Results 91 to 100 of about 173,404 (232)
BMC Cardiovascular Disorders, 2018 The potential life-threatening consequences of catecholamine use for emergency circulatory support in Takotsubo cardiomyopathy-related acute heart failure is a major challenge in cardiovascular emergences.
Michael Dandel, Roland Hetzer
doaj +1 more source
COVID-19-associated takotsubo cardiomyopathy
BMJ Case Reports, 2020 The novel COVID-19 has had an unprecedented and devastating spread internationally. COVID-19 infection can lead to a number of cardiovascular sequelae, including heart failure, which may portend worse clinical outcomes.
J. Gomez +5 more
semanticscholar +1 more source
An Unusual Mid‐Ventricular Takotsubo Cardiomyopathy: A Case Report
Clinical Case Reports, Volume 13, Issue 11, November 2025.ABSTRACT Takotsubo cardiomyopathy (TTC), also known as stress cardiomyopathy, is characterized by transient regional wall motion abnormalities that mimic acute coronary syndrome (ACS) but without obstructive coronary artery disease. Among its various forms, the mid‐ventricular variant is uncommon and diagnostically challenging.
Ibrahim Antoun +4 more
wiley +1 more source
Hyponatremia – an unusual trigger of Takotsubo cardiomyopathy
Revista Portuguesa de Cardiologia, 2011 Takotsubo cardiomyopathy is an acute cardiac entity with clinical manifestations similar to myocardial infarction, accounting for 1-2% of acute coronary syndrome admissions. Its underlying pathophysiology is not yet well established.
Mário Santos +9 more
doaj +1 more source
Open Heart, 2020 Background Cardiac involvement with COVID-19 is increasingly being recognised. Clinical characteristics and outcomes of patients with COVID-19 complicated by secondary Takotsubo cardiomyopathy (TC) is poorly understood.
Shruti Hegde +3 more
semanticscholar +1 more source
Reversible ST‐T Segment Changes Induced by Anamorelin: A Case Report
Respirology Case Reports, Volume 13, Issue 11, November 2025.Anamorelin, which has been approved for cancer cachexia in Japan, has been known to cause adverse events including QT prolongation and can lead to fatal arrhythmia. We report the first case of a male patient with non‐small cell lung cancer who showed ST‐T segment change following anamorelin.
Hayato Akaishi +6 more
wiley +1 more source
Takotsubo cardiomyopathy and COVID-19 infection
European Heart Journal-Cardiovascular Imaging, 2020 Cardiovascular manifestations of coronavirus disease 2019 (COVID-19) include myocardial injury, myocarditis, and cardiac arrhythmias. Recent reports have demonstrated Takotsubo cardiomyopathy (TCM) as a complication of COVID-19.
Husam M. Salah, J. Mehta
semanticscholar +1 more source
JACC: Basic to Translational Science, 2018 Summary: Takotsubo cardiomyopathy is an acute stress-induced heart failure syndrome for which the exact pathogenic mechanisms are unclear, and consequently, no specific treatment exists.
Heather M. Wilson, BSc, PhD +8 more
doaj +1 more source
Advanced cardiac magnetic resonance imaging in takotsubo cardiomyopathy.
British Journal of Radiology, 2020 Takotsubo cardiomyopathy (TC) is a reversible condition in which there is transient left ventricular (LV) dysfunction characterised most commonly by basal hyperkinesis and mid-apical LV ballooning and hypokinesia. It is said to be triggered by stress and
V. Ojha +3 more
semanticscholar +1 more source